Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

BuzzRx® Medical Advisor Dr. Cedric "Jamie" Rutland Joins Mo News Podcast to Discuss the State of American Health

BuzzRx is a free prescription discount card benefiting nonprofits year-round. Save up to 80% on prescription medications at over 60,000 pharmacies nationwide. Search your medication and get the card that gives back on BuzzRx.com. (PRNewsfoto/BuzzRx)

News provided by

BuzzRx

Jun 02, 2025, 09:05 ET

Share this article

Share toX

Share this article

Share toX

Topics Range From the High Cost of Insurance to the Rise of GLP-1 Weight Loss Drugs

PHOENIX, June 2, 2025 /PRNewswire/ -- In an eye-opening new podcast episode of Mo News, journalist and podcast host Mosheh Oinounou sits down with Dr. Cedric "Jamie" Rutland—a triple board certified critical care physician and Medical Advisor for BuzzRx—to unpack some of the most pressing issues in American healthcare today. The discussion spans topics ranging from the crippling cost of insurance to the growing popularity of GLP-1 medications like Ozempic and Wegovy. BuzzRx, a free prescription savings service that allows users to instantly find the lowest price on their medication at pharmacies nationwide, can help users save on a wide variety of prescription medications (like GLP-1s) and help fill in gaps in insurance.

With over 91 million Americans reporting they cannot afford quality healthcare if they needed it today, Dr. Rutland and Mosheh explore why the U.S. healthcare system has become so prohibitively expensive—and what patients can do to navigate it.

"A lot of it comes down to a system that prioritizes profit over patient access," says Dr. Rutland. Between rising hospital costs, pharmaceutical pricing, and complex insurance negotiations, it's the average American who ends up paying the price—literally.

Dr. Rutland highlights how patients increasingly delay care, skip prescriptions, or split doses due to costs—even if they have insurance. As a solution, he emphasizes the role BuzzRx plays in helping bridge that affordability gap.

"I tell all my patients about BuzzRx. It's a free prescription savings tool that can help you save up to 80% on your medications," Rutland explains. "In fact, the average BuzzRx user saves about $1,100 a year—equivalent to the cost of a new iPhone or multiple car payments."

Additionally, the hot topic of GLP-1 medications, such as Ozempic®, Wegovy®, and Mounjaro®, which have skyrocketed in popularity for their weight-loss benefits, is discussed. Rutland breaks down how these medications work, how much weight patients can expect to lose, and what side effects and risks users should consider.

"GLP-1s are changing lives," Dr. Rutland notes. "But they're also expensive—over $1,000 a month in some cases. Even with insurance, cost is often a barrier. That's where services like BuzzRx make a real difference. Since January 2023, BuzzRx users have saved over $4.5 million on semaglutide alone."

Dr. Rutland also shares emerging research on other health benefits tied to GLP-1s, including reduced inflammation and improved sleep apnea outcomes, pointing to a promising future for the class of drugs.

"We're just scratching the surface of what GLP-1 medications can do," he says. "The more we learn, the more possibilities we unlock— for potentially treating and preventing numerous diseases."

The episode offers practical advice for patients, from talking to their doctor to exploring medication discounts via the BuzzRx mobile app or website.

Listen to the full podcast episode on any major podcast platform or YouTube. Mo News fans have the opportunity for additional savings of up to $5 off their first prescription fill with BuzzRx by visiting BuzzRx.com/MoNews.

About Dr. Cedric "Jamie" Rutland:
Cedric "Jamie" Rutland, MD, FCCP, is a triple board-certified Pulmonary, Critical Care, and Internal Medicine physician and owner of Rutland Medical Group, a private practice in Newport Beach, CA. Dr. Rutland is also BuzzRx's Medical Advisor as of 2025 and the owner of Medicine Deconstructed Productions, a company that produces medical education for healthcare companies and the general population. He serves as Vice President for the nonprofit organization AHSM, whose mission is to preserve the integrity of online medical information. He is a sought-after speaker, educator, and thought leader, having contributed to numerous medical publications and public health initiatives. He is also the podcast host of "The Health Exchange" and an internationally recognized speaker and educator.

Prior to forming his own companies, Dr. Rutland completed his Bachelor of Science from the University of California, Davis, medical school, and Internal Medicine residency from the University of Iowa Carver College of Medicine, and completed his fellowship in Pulmonary and Critical Care from the University of Kansas Medical Center. He is also an expert in asthma, chronic obstructive pulmonary disease, interstitial lung disease, endobronchial ultrasound, navigational bronchoscopy, and vaping-related lung injury.

About Mo News:
Mo News is a leading independent news platform and podcast hosted by veteran journalist Mosheh Oinounou. Mo News delivers fact-based reporting and insightful interviews to help audiences make sense of complex issues shaping today's world.

Press Contact
[email protected]

SOURCE BuzzRx

21%

more press release views with 
Request a Demo

Modal title

Also from this source

BuzzRx® Announces Recipients of 2025 Bee Healthy Scholarship Fund

BuzzRx® Announces Recipients of 2025 Bee Healthy Scholarship Fund

BuzzRx, a free prescription savings service that allows users to instantly find the lowest price on their medication at pharmacies nationwide, today...

BuzzRx Celebrates Granting 800th Wish with Make-A-Wish®

BuzzRx Celebrates Granting 800th Wish with Make-A-Wish®

BuzzRx, a free prescription savings service that allows users to instantly find the lowest price on their medication at pharmacies nationwide,...

More Releases From This Source

Explore

Radio

Radio

Entertainment

Entertainment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.